Anthony Dobranowski
Director/Board Member bei NUVO PHARMACEUTICALS INC.
Vermögen: 29 500 $ am 29.02.2024
Profil
Anthony E.
Dobranowski is an Independent Director at Nuvo Pharmaceuticals, Inc. since 2011 and the Lead Independent Director at Crescita Therapeutics, Inc. since 2016.
Previously, he served as the Vice Chairman, President, CFO & Executive VP at Tesma International, Inc. from 1995 to 2012 and as the Vice President at Magna International, Inc. from 2005 to 2007.
He also has experience as a Trustee at Heating Oil Partners Income Fund.
Mr. Dobranowski holds undergraduate and MBA degrees from the University of Toronto.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 24.04.2023 | 100 000 ( 0,50% ) | 29 500 $ | 29.02.2024 |
Aktive Positionen von Anthony Dobranowski
| Unternehmen | Position | Beginn |
|---|---|---|
| NUVO PHARMACEUTICALS INC. | Director/Board Member | 21.09.2004 |
| CRESCITA THERAPEUTICS INC. | Director/Board Member | 01.03.2016 |
Ehemalige bekannte Positionen von Anthony Dobranowski
| Unternehmen | Position | Ende |
|---|---|---|
| MAGNA INTERNATIONAL INC. | Corporate Officer/Principal | 01.09.2007 |
Tesma International, Inc.
 Tesma International, Inc. Auto Parts: OEMProducer Manufacturing Tesma International, Inc. is used to manufacture engine, transmission and fueling components. Its engine productsuesd to include oil and water pumps, as well as pulleys and tensioners. Its transmission systems uesd to include torque converters and clutch housings. Its offerings uesd to include cap-to-tank refueling modules. It was located in Concord, Canada | President | - |
| Heating Oil Partners Income Fund | Director/Board Member | - |
Ausbildung von Anthony Dobranowski
| University of Toronto | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MAGNA INTERNATIONAL INC. | Producer Manufacturing |
| CRESCITA THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Tesma International, Inc.
Tesma International, Inc. Auto Parts: OEMProducer Manufacturing Tesma International, Inc. is used to manufacture engine, transmission and fueling components. Its engine productsuesd to include oil and water pumps, as well as pulleys and tensioners. Its transmission systems uesd to include torque converters and clutch housings. Its offerings uesd to include cap-to-tank refueling modules. It was located in Concord, Canada | Producer Manufacturing |
Nuvo Pharmaceuticals, Inc.
 Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
| Heating Oil Partners Income Fund | Miscellaneous |
